Blood Plasma Derivatives Market Insights and Forecast 2025-2030 - Grifols, SK Plasma, and Fusion Health Care Lead the Competition
Portfolio Pulse from
The blood plasma derivatives market is projected to grow at a CAGR of approximately 9% from 2025 to 2030, driven by the rising incidence of hemophilia, immunological disorders, and an increasing number of surgical procedures. Key players in this market include Grifols, SK Plasma, and Fusion Health Care.
February 06, 2025 | 11:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Grifols is a leading player in the blood plasma derivatives market, which is expected to grow at a CAGR of ~9% from 2025 to 2030 due to rising health conditions and surgical procedures.
Grifols is highlighted as a leading competitor in a market expected to grow significantly. This positions the company well for revenue growth, positively impacting its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80